Edwin S.H. Leong Centre for Healthy Aging
The Edwin S.H. Leong Centre for Healthy Aging brings together researchers across disciplines at UBC to harness the science of healthy aging in order to help people in British Columbia, across Canada, and around the world stay healthy, happy, and active as they age.
The Centre seeks to transform healthy aging by expanding interdisciplinary research focused on the biological, social, cultural and environmental factors that influence aging trajectories and harnessing this information to devise new strategies to promote healthy aging for all.
Our concept of healthy aging is built on the World Health Organization’s definition of healthy aging as the process of developing and maintaining the functional ability that enables wellbeing in older age. Functional ability is having the capabilities that enable people to be and do what they value. Importantly, there is no “typical” healthy older person, and this definition of healthy aging does not require an individual to be free of diseases or health conditions.
Campus
Affiliated UBC Faculty & Postdocs
| Name | Role | Research Interests |
|---|---|---|
| McKay, Heather | Faculty (G+PS eligible/member) | Population health interventions; Aging process; Social and biological determinants of aging; Health promotion and disease prevention; Prevention, treatment and support of youth health; Medical, health and life sciences; Knowledge translation and implementation science in health; Health and community services; Aging Process; Public and Population Health |
| Taubert, Stefan | Faculty (G+PS eligible/member) | Other health sciences; Gene regulation and expression; Transcriptomics; Genomics; Aging; beta cells; C. elegans; Diabetes; Gene Regulation and Expression; Gene regulation; Genetics of Aging; genomics; Hypoxia; Metabolism; Molecular Genetics; Mouse; stress; Stress and Cancer; Stress responses; Toxin and Toxicant Metabolism; Transcription |
| Tremlett, Helen | Faculty (G+PS eligible/member) | Epidemiology (except nutritional and veterinary epidemiology); multiple sclerosis; Neuroepidemiology; Pharmacoepidemiology; prodrome,; Drug safety and effectiveness; Pharmacogenomics; comorbidities; health administrative data; Gut microbiome; prodromes |